Shattuck Labs (STTK) Enterprise Value (2019 - 2026)
Shattuck Labs (STTK) reported Enterprise Value of -$90.4 million for Q1 2026, down 48.48% year-over-year from -$175.5 million in Q1 2025, and down 15.83% quarter-over-quarter from -$78.1 million in Q4 2025.
Shattuck Labs (STTK) Enterprise Value (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Enterprise Value data on file, last reported at -$90.4 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$90.4 million, down 48.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$90.4 million (down 48.48% YoY), and the FY2025 annual result was -$78.1 million, down 6.96% from the prior year.
- Enterprise Value declined to -$90.4 million in Q1 2026 per STTK's latest filing, from -$78.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$50.5 million in Q2 2025 and troughed at -$239.2 million in Q1 2022.
- A 5-year average of -$119.6 million and a median of -$105.3 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value surged 52.09% in 2025, then tumbled 48.48% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$161.3 million in 2022, then rose by 19.01% to -$130.6 million in 2023, then jumped by 44.12% to -$73.0 million in 2024, then declined by 6.96% to -$78.1 million in 2025, then dropped by 15.83% to -$90.4 million in 2026.
- Business Quant data shows STTK's Enterprise Value at -$90.4 million in Q1 2026, -$78.1 million in Q4 2025, and -$86.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | -90.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.42 Mn |
| Dec 31, 2025 | -78.07 Mn |
| Sep 30, 2025 | -86.13 Mn |
| Jun 30, 2025 | -50.47 Mn |
| Mar 31, 2025 | -60.90 Mn |
| Dec 31, 2024 | -72.99 Mn |
| Sep 30, 2024 | -90.06 Mn |
| Jun 30, 2024 | -105.34 Mn |
| Mar 31, 2024 | -114.63 Mn |
| Dec 31, 2023 | -130.63 Mn |
| Sep 30, 2023 | -101.07 Mn |
| Jun 30, 2023 | -117.17 Mn |
| Mar 31, 2023 | -135.50 Mn |
| Dec 31, 2022 | -161.28 Mn |
| Sep 30, 2022 | -185.11 Mn |
| Jun 30, 2022 | -214.24 Mn |
| Mar 31, 2022 | -239.23 Mn |
| Dec 31, 2021 | -268.80 Mn |
| Sep 30, 2021 | -290.22 Mn |
| Jun 30, 2021 | -304.80 Mn |